 |
Video: What is a Stock Split?
|
 |
Insys Therapeutics is a commercial-stage pharmaceutical company that develops and commercializes supportive care products. Co. has two marketed product: SUBSYS®, a proprietary sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS®, a proprietary, orally administered liquid formulation of dronabinol for the treatment of Chemotherapy-induced nausea and vomiting and anorexia associated with weight loss in patients with AIDS. Co.'s other product candidates include other dronabinol line extensions and sublingual spray product candidates. According to our INSY split history records, INSY has had 3 splits. | |
 |

INSY (INSY) has 3 splits in our INSY split history database. The first split for INSY took place on July 18, 2011. This was a 1 for 61 reverse split, meaning for each 61 shares of INSY owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 16.3934426229508 share position following the split. INSY's second split took place on March 31, 2014. This was a 3 for 2 split, meaning for each 2 shares of INSY owned pre-split, the shareholder now owned 3 shares. For example, a 16.3934426229508 share position pre-split, became a 24.5901639344262 share position following the split. INSY's third split took place on June 08, 2015. This was a 2 for 1 split, meaning for each share of INSY owned pre-split, the shareholder now owned 2 shares. For example, a 24.5901639344262 share position pre-split, became a 49.1803278688525 share position following the split.
When a company such as INSY splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as INSY conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the INSY split history from start to finish, an original position size of 1000 shares would have turned into 49.1803278688525 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into INSY shares, starting with a $10,000 purchase of INSY, presented on a split-history-adjusted basis factoring in the complete INSY split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/11/2015 |
|
End date: |
06/18/2019 |
|
Start price/share: |
$25.64 |
|
End price/share: |
$0.29 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.87% |
|
Average Annual Total Return: |
-64.33% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$113.09 |
|
Years: |
4.35 |
|
|
 |
Date |
Ratio |
07/18/2011 | 1 for 61 | 03/31/2014 | 3 for 2 | 06/08/2015 | 2 for 1 |
|
 |